Industry trends

Belgian biotech company raised $100 million in round C financing supported by Pfizer and ALK-5 inhibitors have started Phase IIa clinical trials

Date:Oct 12,2023
Author:Angelo Corporation - reprinted by Shenghui


Recommend Company News